Cadila Pharmaceuticals Sweden Aktiebolag

ABIn liquidation

Org 5569230997Manufacture of pharmaceutical preparations · NACE 2120Est. 20130 employees

Overview Financials People & ownership Related companies

Cadila Pharmaceuticals Sweden Aktiebolag is a Swedish AB, operating in the Tillverkning av läkemedel sector. Incorporated in 2013, the company has 0 employees and reported revenue of SEK 0 in its latest annual filing.

Revenue 2020

SEK 0

EBITDA margin

—

+85% vs 2019

Equity ratio

75.1%

Financial strength

Net profit 2020

SEK -183K

+86% vs 2019

EBITDA — year on year

SEK millions

Key figures

Annual report 2020

Revenue	SEK 0	—
EBITDA	SEK -183K	+85%
Net profit	SEK -183K	+86%
Total assets	SEK 615K	-24%
Equity	SEK 462K	-28%
Employees	0	—

Contact

Address

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of Cadila Pharmaceuticals Sweden Aktiebolag?

Cadila Pharmaceuticals Sweden Aktiebolag is registered with Bolagsverket / SCB under Org 5569230997.

Who is the CEO of Cadila Pharmaceuticals Sweden Aktiebolag?

Jonny Lennart Greinsmark is Liquidator of Cadila Pharmaceuticals Sweden Aktiebolag, in role since 2020.

Cadila Pharmaceuticals Sweden Aktiebolag

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Cadila Pharmaceuticals Sweden Aktiebolag

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Cadila Pharmaceuticals Sweden Aktiebolag